{"product_id":"9781461416616","title":"SpringerBriefs in Pharmaceutical Science \u0026 Drug Development","description":"\u003ch1\u003eSpringerBriefs in Pharmaceutical Science \u0026amp; Drug Development\u003c\/h1\u003e \u003ch2\u003eTurner, J. Rick\u003c\/h2\u003e \u003cp\u003eThis Brief discusses key statistical concepts that facilitate the inferential analysis of data collected from a group of individuals participating in a pharmaceutical clinical trial, the estimation of their clinical significance in the general population of individuals likely to be prescribed the drug if approved, and the related decision-making that occurs at both the public health level (by regulatory agencies when deciding whether or not to approve a new drug for marketing) and the individual patient level (by physicians and their patients when deciding whether or not the patient should be prescribed a drug that is on the market). These concepts include drug safety and efficacy, statistical significance, clinical significance, and benefit-risk balance.\u003c\/p\u003e \u003ch3\u003eDetails\u003c\/h3\u003e \u003cp\u003ePublished by: Springer\u003c\/p\u003e \u003cp\u003ePublication Date: 2011-10-13\u003c\/p\u003e \u003cp\u003eFormat: Paperback\u003c\/p\u003e \u003cp\u003eISBN-13: 9781461416616\u003c\/p\u003e \u003cp\u003eDOI: 10.1007\/978-1-4614-1662-3\u003c\/p\u003e \u003cp\u003eDimensions: 235cm x155cm\u003c\/p\u003e \u003cp\u003ePages: 61\u003c\/p\u003e ","brand":"Springer New York","offers":[{"title":"Default Title","offer_id":47401577283724,"sku":"9781461416616","price":49.49,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9781461416616.jpg?v=1775794801","url":"https:\/\/lateknightbooks.com\/products\/9781461416616","provider":"Late Knight Books and Services, LLC","version":"1.0","type":"link"}